| Literature DB >> 25051180 |
Michele Tinazzi1, Alfonso Fasano2, Alessia Peretti1, Francesco Bove3, Antonella Conte4, Carlo Dallocchio, Carlo Dall'Occhio5, Carla Arbasino5, Giovanni Defazio6, Mirta Fiorio1, Alfredo Berardelli4.
Abstract
BACKGROUND AND METHODS: In order to obtain further information on the pathophysiology of functional tremor, we assessed tactile discrimination threshold and proprioceptive temporal discrimination motor threshold values in 11 patients with functional tremor, 11 age- and sex-matched patients with essential tremor and 13 healthy controls.Entities:
Mesh:
Year: 2014 PMID: 25051180 PMCID: PMC4106827 DOI: 10.1371/journal.pone.0102328
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic and clinical features in the patients with functional tremor (FT) and essential tremor (ET).
| Group | N | Sex | Age | Tremor duration (yrs) | Tremor distribution | Other movement disorders | TRS | Management (daily dose mg) |
| FT | 1 | F | 70 | 3 | UL | None | 21 | Propranolol (40), Clonazepam (2.5) |
| FT | 2 | M | 23 | 13 | UL | None | 26 | Propranolol (40) |
| FT | 3 | F | 44 | 14 | UL,HEAD | Torticollis | 13 | Pregabalin (100), Clonazepam (2.5) |
| FT | 4 | F | 60 | 2 | UL | None | 6 | Venlafaxine (300) |
| FT | 5 | M | 31 | 3 | L UL | L UL dystonia | 9 | None |
| FT | 6 | F | 63 | 8 | UL | None | 35 | Primidone (250) |
| FT | 7 | M | 59 | 6 | UL,LL | None | 36 | Propanolol (40) |
| FT | 8 | M | 45 | 7 | L UL,L LL | L Knee buckling | 7 | Lorazepam(2.5) |
| FT | 9 | F | 57 | 21 | L UL, HEAD | None | 5 | Citalopram (10) |
| FT | 10 | M | 23 | 5 | R UL | None | 1 | None |
| FT | 11 | F | 46 | 6 | UL | None | 8 | None |
|
|
|
|
|
| ||||
| ET | 1 | M | 65 | 37 | UL | None | 15 | None |
| ET | 2 | M | 52 | 8 | UL | None | 8 | Propanolol (40) |
| ET | 3 | F | 68 | 41 | UL | None | 15 | Bromazepam (0.5) |
| ET | 4 | M | 54 | 6 | UL | None | 9 | None |
| ET | 5 | M | 58 | 7 | UL | None | 4 | None |
| ET | 6 | F | 59 | 5 | UL, HEAD | None | 35 | Propanolol (40), Clonazapam (2.5) |
| ET | 7 | F | 23 | 5 | UL | None | 14 | Clonazepam (2.5) |
| ET | 8 | F | 30 | 6 | UL | None | 21 | Primidone (250) |
| ET | 9 | F | 45 | 4 | UL | None | 10 | Lorazepam (1) |
| ET | 10 | F | 40 | 8 | UL | None | 26 | Propanolol (40) |
| ET | 11 | M | 43 | 5 | UL | None | 18 | Propanolol (40) |
|
|
|
|
|
|
Abbreviations: M: male; F: female; R: right, L: left; UL: upper limb(s); LL: lower limb(s); TRS: tremor rating score (see methods).
Figure 1TDT and TDMT in patients with ET, FT and healthy controls.
A) Tactile temporal discrimination thresholds (TDT) obtained in healthy controls (HC), patients with essential tremor (ET) and functional tremor (FT) after stimuli applied separately to the right (blue bars) and left (grey bars) hand; B) Temporal discrimination movement thresholds (TDMT) obtained in HC, and patients with ET, and FT after stimuli applied separately to the right (blue bars) and left (grey bars) first dorsal interosseous (FDI); C) and flexor carpii radialis (FCR) muscles.